메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

The Veteran Suite partners with QENDO to advocate for female veteran care

SYDNEY, Sept. 1, 2025 -- The Veteran Suite, a medical centre exclusively for Australian veterans and their families, has launched a new partnership with QENDO, an Australian organisation providing support and education for those affected by endometriosis, adenomyosis, PCOS, infertility or pelvic pain. Partnering with QENDO, The Veteran Suite aims to deliver targeted support for female veterans and their families, and raise awareness as to the support that both QENDO and The Veteran Suite can provide. The Veteran Suite was founded as a telehealth-first clinic with a mission to reduce ba
- 김갑성 기자
- 2025-09-01 08:00
MarcumAsia Expands with Opening of Japan Office in Tokyo

TOKYO, Sept. 1, 2025 -- Marcum Asia CPAs LLP ("MarcumAsia"), a leading independent public accounting firm specializing in SEC and PCAOB-compliant audits for Asian companies listing in the United States, today announced the official opening of its new office in Tokyo, Japan. Located on the 27th floor of the Tokyo Sankei Building in Otemachi, Chiyoda-ku, the new office will serve as a strategic hub to support Japanese corporates, financial institutions, and advisors seeking access to U.S. capital markets through IPOs, SPAC/De-SPAC transactions, and ongoing
- 황정호 기자
- 2025-09-01 07:30
麥楷亞洲東京に日本オフィスを開設

東京, 2025年9月1日 -- アジア企業の米国上場を支援するSEC・PCAOB準拠監査を専門とする独立系会計事務所麥楷亞洲（Marcum Asia CPAs LLP）は、東京・千代田区大手町の東京サンケイビル27階に日本オフィスを正式開設いたしました。新オフィスは、日本企業、金融機関、アドバイザーが米国資本市場へアクセスするための戦略拠点として機能し、IPO、SPAC/De-SPAC、SEC報告対応など幅広いサービスを提供します。日本業務統括責任者劉戎は次のように述べています。「日本は世界有数のイノベーション拠点です。東京オフィスの開設により、麥楷亞洲は日本企業と米国公開市場を結ぶ体制を一層強化します。」今回の拠点開設は、2024年に25件のIPOの監査報告書を発行し、米国におけるアジア企業のSEC監査件数で第1位を達成した実績をさらに発展させるものです。麥楷亞洲は DFK International および LEA Global に加盟しており、クライアントはグローバルネットワークを活用して国際展開を推進できます。麥楷亞洲日本オフィス〒100-0004 東京都千代田区大手町1丁目7-2 東京サンケイビル27階Phone: +81 3 3
- 황정호 기자
- 2025-09-01 07:30
ADAM BRADLEY JOINS AUTOMIC GROUP AS CHIEF GROWTH OFFICER TO ACCELERATE ASX200 EXPANSION

SYDNEY, Sept. 1, 2025 -- Automic Group, Australia's market leader in technology-driven investor administration and services, announces the appointment of Adam Bradley as its Chief Growth Officer to accelerate market expansion and the Group's presence in the ASX200 segment. Adam brings over 25 years of experience in the financial services and technology sectors across Australia and the United Kingdom. His career is marked by a proven track record of leading growth initiatives and scaling technology businesses at major financial institutions including the Australian Securities Exchange (
- 황정호 기자
- 2025-09-01 07:00
CJ 4DPLEX and SM Cinema to Bring First 270-Degree Panoramic SCREENX Auditorium to the Philippines

Set to Launch at SM Mall of Asia in Pasay City, the Country's Largest Mall BURBANK, Calif., Sept. 1, 2025 -- CJ 4DPLEX, a worldwide leading producer of premium film formats and cinema technologies, announced today a new partnership with SM Cinema, the largest exhibitor in the Philippines, to debut the country's first-ever SCREENX theater to the SM Mall of Asia. This agreement will introduce CJ 4DPLEX's 270-degree panoramic SCREENX format to Filipino moviegoers for the very first time. SCREENX enhances the traditional movie experience by extending the image across the ma
- 김장윤(JASON KIM) 기자
- 2025-09-01 06:00
Arclin、Kevlar®およびNomex®ブランドを含むAramids事業をDuPont™社から買収する正式契約を締結

Arclinのイノベーション・プラットフォームを拡大し補完するために両ブランドを買収ジョージア州アルファレッタ、2025年8月31日 -- Arclinは本日、Kevlar®およびNomex®ブランドを含むDuPontのAramids事業を約18億ドルで買収する正式契約を締結したと発表しました。計画されている買収により、Arclinのポートフォリオは航空宇宙、電気インフラ、電気自動車、個人用保護具、防衛にまで拡大し、建設、インフラ、気象・防火、輸送における強固な地位をさらに強化することになります。Arclinの最先端技術はミッションクリティカルなものであり、日々の生活を守り、向上させる重要な製品を推進します。この取引は、慣習的な完了条件と規制当局の承認を条件に、2026年第1四半期に完了する予定です。ArclinはTJC, L.P.の関連会社のポートフォリオ企業です。「Kevlar®とNomex®のブランドは、その革新性と保護品質で長年知られています」とArclinの社長兼最高経営責任者のBradley Bolducは述べています。「今回の買収計画により、Arclinはこれらのブランドの潜在能力を解き放ち、住宅、職場、地域社会をより強固で安全、かつ強靭にする先進素材の新時代を切り開くことになるでしょう
- 김갑성 기자
- 2025-08-31 12:06
마이디어 그룹, 2025년 상반기 사상 최고 실적 달성

[ 메디채널 황정호 기자 ] 포산, 중국 2025년 8월 31일 -- 글로벌 가전 기업인 마이디어 그룹(Midea Group)이 2025년 상반기 사상 최고 실적을 달성했다. 매출은 전년 동기 대비 15.7% 증가한 2520억 위안을 기록하며, 2분기 연속 매출이 1000억 위안을 돌파했다. 순이익도 260억 위안으로 전년 동기 대비 25% 급증했다. 중국 본토 매출은 14.2% 증가하며 자국 내 강력한 시장 지위를 보여줬고, 해외 매출도 무려 17.7%나 성장했다. OBM(Original Brand Manufacturing) 사업 부문에선 전자상거래 매출이 전년 동기 대비 30% 이상 늘어나는 두드러진 매출 성장세를 보였다. 또한 마이디어 그룹은 상반기에 테카 그룹(Teka Group, 러시아 자회사 제외) 인수를 완료했다. 소비자 부문(ToC) 매출은 1670억 위안으로 13.3% 증가했고, 상업•산업 부문(ToB) 매출 역시 20%가 늘어났다. 신에너지 및 산업 기술 부문 매출은 220억 위안, 지능형 빌딩 기술 매출은 195억 위안, 로봇 및 자동화 부문 매출은 151억 위안을 각각 기록했다. 마
- 황정호 기자
- 2025-08-31 03:54
Global Trade Review Announces GTR Asia 2025 in Singapore - the premier platform for the trade community in the Asia Pacific region - hits over 1,500 registration for September 2-3

SINGAPORE, Aug. 30, 2025 -- Global Trade Review (GTR) is delighted to announce the return of GTR Asia 2025, taking place in Singapore on September 2–3, 2025. Serving as the premier platform for the Asia Pacific trade community, the annual event will once again bring together senior decision-makers from across trade and supply chain finance, commodity finance, fintech, and treasury. Building on its reputation as the region's most anticipated trade finance gathering, GTR Asia 2025 will deliver dynamic and engaging formats aimed at maximising audience participat
- 황정호 기자
- 2025-08-30 23:39
SENGKANG GENERAL HOSPITAL HOLDS MEN'S HEALTH FORUM TO CHAMPION PREVENTIVE CARE AND WELLBEING AMONG MEN IN SINGAPORE

Debut of "Man Up!" Book by SKH Urologist Challenges Health Barriers Among Men SINGAPORE, Aug. 30, 2025 -- Taking a step to shift mindsets and spark lasting change in how men approach their health, Sengkang General Hospital (SKH) held a Men's Health Public Forum themed "Be There, For the People Who Matter" at Suntec Convention Centre today. Bringing together close to 300 registered participants from all walks of life, this event reflected the hospital's deepening focus on preventive healthcare, early intervention, and empowering men with the to
- 노기식 기자
- 2025-08-30 21:33
成長への入り口：第8回CIIEにおけるイノベーションと機会

[ 메디채널 황정호 기자 ] 上海、2025年8月30日 -- 世界経済が変化する中、中国国際輸入博覧会（China International Import Expo、CIIE）は引き続き世界企業にとって重要な入り口となっています。第8回CIIEの準備は順調に進んでおり、この博覧会では再びイノベーションを披露し、協力を促進し、中国のダイナミックな市場へのアクセスを拡大する予定です。世界中の企業が中国の巨大な市場にアクセスするために重要なこの場を活用し、多くの出展者が参加者から投資家へと成長し、多くの展示品が市場性のある商品へと変化しました。たとえば、Novartisは第4回CIIEで放射性リガンド療法（Radioligand Therapy、RLT）を発表しました。同社はCIIEの波及効果を活用し、第7回CIIEでGE Healthcare China、Shanghai Pharmaceutical Holding、Chongqing Pharmaceutical Holdingの3つの中国パートナーと戦略的協定を締結し、中国でのRLTの立ち上げと拡大を加速させました。第8回CIIEの需給マッチング・イベントでは、企業が22の「CIIEベイビー」を展示しました。これは、以前の博覧会でデビューした後、市場にうまく参入した製品
- 황정호 기자
- 2025-08-30 20:57

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-09-04_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 04일 12시 20분